European Fact Sheet on Hepatitis of Unknown Cause in Children

• Facebook
• Twitter
• Reddit
• Tumblr
• LinkedIn
• Pinterest
• RSS Feed
• Link

European Fact Sheet on Hepatitis of Unknown Cause in Children

• FDA Investigates T-Cell Malignancy Risk in CAR-T Cell Therapy
• WHO Requests More Information from China on Pediatric Clustered Pneumonia
• First Chinese PD-1 Cancer Drug 30 Times More Expensive in U.S. than in China
• Cardiovascular Diseases Linked to COVID-19 Infections
• What is the difference between dopamine and dobutamine?
• How long can the patient live after heart stent surgery?

European Fact Sheet on Hepatitis of Unknown Cause in Children.

This report provides an overview of cases of unexplained hepatitis in children 16 years of age and younger reported by the European Centre for Disease Control (ECDC) Surveillance System (TESSy) to the ECDC and the World Health Organization (WHO) Regional Office for Europe.

As of May 13, 2022, a total of 232 cases of acute hepatitis of unknown etiology in children 16 years of age and younger had been reported in 14 countries, of which 229 were suspected cases and 3 had epidemiological links. Among them, 12 cases in Belgium, 2 cases in Cyprus, 6 cases in Denmark, 2 cases in Greece, 6 cases in Ireland, 24 cases in Italy, 6 cases in the Netherlands, 5 cases in Norway, 1 case in Poland, 1 case in Serbia, 1 case in Slovenia, and 26 cases in Spain. There are 9 cases in Sweden and 131 cases in the UK.

Of the 229 suspected cases, 122 have recovered and 18 are still receiving treatment.

The curve shows the date children first developed symptoms, with an increase in the number of cases from week 9. Because it can take time to develop severe hepatitis after the first symptom onset, and investigations take time, there may be delays in case reporting, and it is difficult to explain the recent decrease in cases (Figure 1).

Figure 1 Weekly number of cases by date of onset

Most (75.9%) patients were under 5 years of age (Figure 2).

Figure 2 Age distribution of children

Of the 143 cases, 22 (15.4%) were admitted to the intensive care unit. Of the 98 cases for which information was available, 6 (6.1%) underwent liver transplantation. One death was related to the disease.

Of the 151 children who underwent adenovirus testing in any specimen, 90 (59.6%) were positive, with the highest positive rate in whole blood specimens (68.9%) (Figure 3).

Figure 3 The number of positive adenovirus detection in different specimens

SARS-CoV-2 PCR testing was performed in 173 children, of which 20 (11.6%) tested positive. Only 19 patients had serological testing for SARS-CoV-2, of which 14 (73.7%) tested positive (Figure 4). Of the 56 infants for which vaccination data were available, 47 (83.9%) had not been vaccinated (Figure 5).

Figure 4 SARS-CoV-2 detection”

Figure 5 Current status of SARS-CoV-2 vaccination

The chart below depicts data on cases of hepatitis of unknown cause in children 16 years of age and younger for countries and territories in the WHO European Region, including 27 European Union (EU) member states and three European Economic Area (EEA) countries (Figure 6).

Figure 6 Number of cases in different regions

Since the UK first issued the alert on 5 April 2022, cases of hepatitis of unknown cause in children have been reported in several countries around the world.

It is unclear whether the number of cases detected after the alert actually increased compared to the baseline incidence.

The etiology and pathogenesis of the disease are still being studied.

A possible association between childhood hepatitis of unknown origin and adenovirus infection is currently considered, but other hypotheses and possible associated factors are still under investigation.

Most of the reported cases are sporadic with no apparent link.

European Fact Sheet on Hepatitis of Unknown Cause in Children

(source:internet, reference only)

Disclaimer of medicaltrend.org

Important Note: The information provided is for informational purposes only and should not be considered as medical advice.